鉄欠乏性貧血(Iron Deficiency Anemia)の治療薬パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Iron Deficiency Anemia Overview 6
Therapeutics Development 7
Pipeline Products for Iron Deficiency Anemia – Overview 7
Pipeline Products for Iron Deficiency Anemia – Comparative Analysis 8
Iron Deficiency Anemia – Therapeutics under Development by Companies 9
Iron Deficiency Anemia – Therapeutics under Investigation by Universities/Institutes 10
Iron Deficiency Anemia – Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Iron Deficiency Anemia – Products under Development by Companies 14
Iron Deficiency Anemia – Products under Investigation by Universities/Institutes 15
Iron Deficiency Anemia – Companies Involved in Therapeutics Development 16
Panion & Bf Biotech Inc 16
Rockwell Medical, Inc. 17
Vifor Pharma AG 18
Iron Deficiency Anemia – Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Route of Administration 20
Assessment by Molecule Type 22
Drug Profiles 24
ferric carboxymaltose – Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
ferric citrate – Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
ferric pyrophosphate citrate – Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
NSC-8679 – Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Proteins to Activate Erythroferrone for Iron Deficiency Anemia – Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
ST-10 – Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
VIT-91 – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Iron Deficiency Anemia – Recent Pipeline Updates 35
Iron Deficiency Anemia – Dormant Projects 49
Iron Deficiency Anemia – Product Development Milestones 50
Featured News & Press Releases 50
Dec 15, 2014: American Regent’s Injectafer (ferric carboxymaltose injection) Assigned J Code by Centers for Medicare & Medicaid Services 50
Dec 08, 2014: American Regent Announces Clinical Data Presentations at ASH 2014 51
Nov 11, 2014: Three clinical Presentations Highlight Novel Iron Replacement Drug Triferic at ASN 53
Oct 09, 2014: Rockwell Medical Announces FDA Advisory Committee Review of Triferic For The Treatment Of Iron Replacement And Maintenance Of Hemoglobin In Hemodialysis Patients 54
Sep 01, 2014: CONFIRM-HF study demonstrates that Ferinject improves exercise capacity in patients with chronic heart failure 54
Jul 15, 2014: American Regent’s Injectafer (Ferric Carboxymaltose Injection) Now the Fastest Growing IV Iron in United States 55
Jun 09, 2014: Rockwell Medical Wins Appeal for Determination as Small Business for New Drug Application Filing for Triferic 56
Jun 02, 2014: Faster, more affordable treatment for Iron Deficiency Anaemia now available in Australia 57
May 28, 2014: Rockwell Medical Announces FDA Acceptance for Filing of Triferic New Drug Application 58
May 22, 2014: Keryx Receives Notification of PDUFA Date Extension for Zerenex 58
Appendix 59
Methodology 59
Coverage 59
Secondary Research 59
Primary Research 59
Expert Panel Validation 59
Contact Us 60
Disclaimer 60